Abstract
Cancer-associated fibroblasts (CAFs) are an important cell type present in solid tumor microenvironments, including that of gastric cancer. They play a vital role in the promotion of tumorigenesis, angiogenesis, and cancer progression through paracrine signaling and modulation of the extracellular matrix. However, the exact molecular mechanism underlying the interaction between gastric cancer cells and stromal fibroblasts remains poorly understood. Recent studies have demonstrated that various factors, such as gene and microRNA variations, are involved in this process. This review discusses recent advances in understanding how these factors are regulated in CAFs and how they affect tumor biology, which may improve our understanding of their role in gastric cancer tumorigenesis and progression and provide new promising targets for therapeutic strategies.
Keywords: Cancer-associated fibroblasts, tumor microenvironment, gastric cancer, tumorigenesis, angiogenesis, extracellular matrix.
Current Pharmaceutical Design
Title:The Role of Cancer-associated Fibroblasts in Tumorigenesis of Gastric Cancer
Volume: 24 Issue: 28
Author(s): Zhilong Ma, Min Chen, Xiaohu Yang, Bin Xu, Zhenshun Song, Bo Zhou*Tingsong Yang*
Affiliation:
- Department of General Surgery, Shanghai Tenth Peoples' Hospital, Tongji University, Shanghai 200072,China
- Department of General Surgery, Shanghai Tenth Peoples' Hospital, Tongji University, Shanghai 200072,China
Keywords: Cancer-associated fibroblasts, tumor microenvironment, gastric cancer, tumorigenesis, angiogenesis, extracellular matrix.
Abstract: Cancer-associated fibroblasts (CAFs) are an important cell type present in solid tumor microenvironments, including that of gastric cancer. They play a vital role in the promotion of tumorigenesis, angiogenesis, and cancer progression through paracrine signaling and modulation of the extracellular matrix. However, the exact molecular mechanism underlying the interaction between gastric cancer cells and stromal fibroblasts remains poorly understood. Recent studies have demonstrated that various factors, such as gene and microRNA variations, are involved in this process. This review discusses recent advances in understanding how these factors are regulated in CAFs and how they affect tumor biology, which may improve our understanding of their role in gastric cancer tumorigenesis and progression and provide new promising targets for therapeutic strategies.
Export Options
About this article
Cite this article as:
Ma Zhilong , Chen Min , Yang Xiaohu , Xu Bin , Song Zhenshun , Zhou Bo *, Yang Tingsong *, The Role of Cancer-associated Fibroblasts in Tumorigenesis of Gastric Cancer, Current Pharmaceutical Design 2018; 24 (28) . https://dx.doi.org/10.2174/1381612824666180601094056
DOI https://dx.doi.org/10.2174/1381612824666180601094056 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Predicting LncRNA-Disease Association Based on Generative Adversarial
Network
Current Gene Therapy The Adrenergic System in Gastrointestinal Cancers
Current Cancer Therapy Reviews Lipid based Nanocarriers for Oral Delivery of Cancer Chemotherapeutics: An Insight in the Intestinal Lymphatic Transport
Drug Delivery Letters Extra-Hematopoietic Effects of Erythropoietin
Cardiovascular & Hematological Disorders-Drug Targets The Clinical Significance of Indocyanine Green Excretion Test in Evaluation of Liver Functional Reserve
Current Signal Transduction Therapy Medicinal Importance of Flavonoid “Eupatorin” in the Health Sectors: Therapeutic Benefit and Pharmacological Activities Through Scientific Data Analysis
Current Chinese Science Recent Advances in 1,3,5-Triazine Derivatives as Antibacterial Agents
Mini-Reviews in Organic Chemistry Herb-Drug Interactions and Mechanistic and Clinical Considerations
Current Drug Metabolism Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews Compounds from Wild Mushrooms with Antitumor Potential
Anti-Cancer Agents in Medicinal Chemistry A Three-gene-based Type 1 Diabetes Diagnostic Signature
Current Pharmaceutical Design Patent Selections
Recent Patents on Food, Nutrition & Agriculture Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Carbon Nanotubes: An Emerging Drug Delivery Carrier in Cancer Therapeutics
Current Drug Delivery Pharmacological Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Therapeutic Antibodies
Current Molecular Medicine Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
Current Medicinal Chemistry Recent Advances in Fluorescent Probes for Monitoring of Hydrogen Sulfide
Current Medicinal Chemistry Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells
Anti-Cancer Agents in Medicinal Chemistry Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells
Current Drug Targets